YNL011C Antibody

What is YNL011C and why is it studied in research?

YNL011C is a gene designation in Saccharomyces cerevisiae (baker's yeast), specifically in the S288c strain (ATCC 204508) . This gene encodes a protein that is the subject of research interest in yeast biology. Baker's yeast serves as an important model organism in molecular biology and genetics research due to its eukaryotic cellular organization, relatively simple genetic structure, and ease of manipulation. Studying YNL011C contributes to our understanding of fundamental cellular processes that may have homologs in higher organisms. Research involving YNL011C antibodies allows for the detection, quantification, and characterization of this protein in experimental systems, providing insights into its expression, localization, and function within yeast cells .

What are the validated applications for YNL011C antibody?

The YNL011C antibody has been specifically validated for two primary research applications: Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) . These applications represent standard protein detection and quantification methods in molecular biology research. ELISA allows for quantitative detection of the target protein in solution, while Western Blotting enables visualization of the protein in cell or tissue lysates, providing information about protein size and relative abundance. When implementing these techniques, researchers should follow established protocols for antibody dilution and sample preparation to ensure optimal results. It's important to note that this antibody is designated for research use only and is not validated for diagnostic or therapeutic procedures .

What are the optimal storage and handling conditions for YNL011C antibody?

Proper storage and handling of the YNL011C antibody are critical for maintaining its functionality and specificity. Upon receipt, the antibody should be stored at either -20°C or -80°C for long-term preservation . Repeated freeze-thaw cycles should be avoided as they can degrade antibody quality and reduce performance in experimental applications. The antibody is supplied in liquid form with a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . When working with the antibody, it's advisable to aliquot it into smaller volumes for single-use applications to minimize freeze-thaw cycles. For short-term storage during experimental procedures, keeping the antibody on ice is recommended to preserve its binding capacity and specificity.

How is the YNL011C antibody produced and purified?

The YNL011C antibody is a polyclonal antibody raised in rabbits using a recombinant YNL011C protein from Saccharomyces cerevisiae (strain ATCC 204508/S288c) as the immunogen . The polyclonal nature means it contains a mixture of antibodies that recognize multiple epitopes on the target protein, potentially increasing detection sensitivity but may also increase the risk of cross-reactivity. The antibody undergoes antigen affinity purification to enhance its specificity for the target protein . This purification method involves immobilizing the target antigen on a solid support and selecting only those antibodies from the serum that bind to the target with high affinity. The resulting purified antibody preparation consists of IgG isotype antibodies specific to the YNL011C protein. Understanding this production process helps researchers interpret experimental results and troubleshoot any specificity issues that may arise.

How can specificity of YNL011C antibody be validated in experimental protocols?

Validating antibody specificity is a critical step in ensuring experimental rigor when working with YNL011C antibody. A comprehensive validation approach should include multiple techniques. First, perform Western blot analysis comparing wild-type yeast cells with YNL011C knockout strains - the antibody should show a band of the expected molecular weight in wild-type samples that is absent in knockout samples . Second, conduct pre-absorption tests by incubating the antibody with excess purified recombinant YNL011C protein before application in your experimental protocol; this should eliminate specific signals if the antibody is truly specific. Third, employ orthogonal methods such as mass spectrometry to confirm the identity of immunoprecipitated proteins. Fourth, test the antibody against closely related yeast proteins to assess cross-reactivity potential. Finally, consider using epitope-tagged versions of YNL011C as additional controls, comparing detection by both the YNL011C antibody and tag-specific antibodies . This multi-faceted approach ensures that experimental findings reflect true YNL011C biology rather than artifacts from non-specific antibody interactions.

What optimization strategies should be employed for Western blot analysis with YNL011C antibody?

Optimizing Western blot protocols for YNL011C antibody requires systematic adjustment of multiple parameters to achieve optimal signal-to-noise ratio. Begin with sample preparation: efficient extraction from yeast cells often requires mechanical disruption (glass beads beating) combined with a lysis buffer containing protease inhibitors to prevent degradation of the target protein . For gel electrophoresis, determine the appropriate acrylamide percentage based on the molecular weight of YNL011C to ensure optimal separation. During transfer, consider using PVDF membranes for their higher protein binding capacity and mechanical strength. For blocking, test both BSA and non-fat dry milk (3-5%) to determine which yields lower background with this specific antibody. Titrate primary antibody concentrations (typically starting with 1:1000 dilution) and incubation conditions (4°C overnight versus room temperature for 1-2 hours) . For detection, compare enhanced chemiluminescence (ECL) with fluorescence-based detection systems to determine which provides optimal sensitivity and dynamic range for your specific research question. Finally, implement appropriate positive and negative controls, including recombinant YNL011C protein and samples from YNL011C knockout strains, to validate the specificity of detected bands.

How can YNL011C antibody be adapted for immunoprecipitation experiments?

While the YNL011C antibody is primarily validated for ELISA and Western blot applications , adapting it for immunoprecipitation (IP) requires careful protocol development. Begin by determining the optimal antibody-to-bead ratio through small-scale titration experiments, typically starting with 2-5μg of antibody per 50μl of Protein A/G beads. Pre-clear lysates thoroughly to reduce non-specific binding, which is particularly important when working with yeast extracts due to their complex composition. Crosslinking the antibody to the beads using dimethyl pimelimidate (DMP) or BS3 can prevent co-elution of antibody heavy and light chains, simplifying downstream analysis. For yeast cell lysis, use conditions that preserve protein-protein interactions if studying YNL011C complexes (e.g., lower salt concentrations, mild detergents like NP-40 or Triton X-100 at 0.1-0.5%). Test different elution conditions to maximize recovery while maintaining protein structure - options include low pH glycine buffer (pH 2.5-3.0), SDS sample buffer, or specific peptide elution if the epitope is known. Always validate IP results using reciprocal pull-downs with known interaction partners when possible, and confirm specificity through mass spectrometry analysis of immunoprecipitated complexes . IP protocols may require significant optimization due to the polyclonal nature of the antibody and the unique characteristics of the yeast proteome.

What approaches can be used to incorporate YNL011C antibody in cellular localization studies?

Determining the subcellular localization of YNL011C protein requires adapting immunofluorescence techniques for yeast cells, which present unique challenges due to their cell wall. Begin with appropriate fixation protocols - typically 3.7% formaldehyde for 30-60 minutes, followed by cell wall digestion using zymolyase or lyticase to create spheroplasts that allow antibody penetration . Optimize permeabilization conditions using detergents like Triton X-100 (0.1-0.5%) or digitonin (25-50μg/ml) depending on the subcellular compartment being studied. For blocking, use 3-5% BSA or normal serum from the species of the secondary antibody. Determine optimal antibody dilutions through titration experiments, typically starting at 1:100 for primary antibody and 1:500 for fluorophore-conjugated secondary antibodies. To enhance signal specificity, consider implementing antigen retrieval techniques if dealing with heavily cross-linked samples. For yeast cells specifically, reference markers for various organelles (nucleus, vacuole, mitochondria, ER) should be included as controls. Confirmation of localization patterns should employ complementary approaches such as subcellular fractionation followed by Western blotting, or fluorescent protein tagging of YNL011C. Advanced imaging techniques like super-resolution microscopy or confocal microscopy with deconvolution may be necessary to precisely map the distribution of YNL011C within yeast subcellular compartments .

How can YNL011C antibody be integrated into high-throughput proteomic workflows?

Incorporating YNL011C antibody into high-throughput proteomic approaches requires strategic adaptation of standard protocols. For antibody-based proteomics, consider developing reverse phase protein arrays (RPPA) where the YNL011C antibody is used to probe multiple samples simultaneously on nitrocellulose-coated slides. This approach allows for quantitative comparison of YNL011C expression across different experimental conditions . For immunoprecipitation coupled with mass spectrometry (IP-MS), optimize lysis conditions to preserve protein-protein interactions while ensuring sufficient extraction efficiency. Scale down IP protocols to microplate format for parallel processing, using magnetic beads for easier handling in automated systems. When integrating with liquid chromatography-mass spectrometry (LC-MS/MS) workflows, develop specific enrichment strategies such as sequential elution from immunoaffinity columns to enhance detection of low-abundance interaction partners . For cross-platform validation, establish standardized positive and negative controls that can be included across all experimental batches. Consider developing computational pipelines specifically designed to analyze YNL011C interaction networks, incorporating prior knowledge from yeast genetic screens and existing protein-protein interaction databases. Integration with the YAbS database methodology may provide valuable frameworks for data organization and analysis in such high-throughput contexts . Finally, implement appropriate statistical methods for dealing with the complex data generated, particularly when comparing results across multiple experimental conditions or genetic backgrounds.

What is the recommended protocol for ELISA using YNL011C antibody?

A methodical approach to ELISA with YNL011C antibody requires careful optimization to achieve reliable quantification of the target protein. Begin by coating high-binding 96-well plates with capture antibody or purified recombinant YNL011C protein depending on whether you're conducting a sandwich or direct ELISA, respectively . For coating, use 50-100μl of antibody diluted in carbonate-bicarbonate buffer (pH 9.6) at concentrations ranging from 1-10μg/ml and incubate overnight at 4°C. After washing with PBS containing 0.05% Tween-20 (PBST), block non-specific binding sites with 1-5% BSA or non-fat dry milk in PBST for 1-2 hours at room temperature. For sample preparation from yeast cultures, optimize extraction conditions to ensure efficient recovery of the YNL011C protein - typically involving mechanical disruption with glass beads in a lysis buffer containing protease inhibitors. Prepare a standard curve using recombinant YNL011C protein at concentrations ranging from 0.1-1000ng/ml. Apply samples and standards to the plate in duplicate or triplicate, incubating for 1-2 hours at room temperature. For detection, dilute the YNL011C antibody to 0.5-2μg/ml in blocking buffer and incubate for 1-2 hours at room temperature . After washing, apply appropriate enzyme-conjugated secondary antibody (typically HRP-conjugated anti-rabbit IgG) at 1:2000-1:5000 dilution for 1 hour. Develop using TMB substrate and measure absorbance at 450nm after stopping the reaction with 2N H₂SO₄. Include appropriate positive controls (recombinant YNL011C) and negative controls (extracts from YNL011C knockout strains) to validate assay specificity.

How should Western blot protocols be structured for optimal YNL011C detection?

A comprehensive Western blot protocol for YNL011C detection includes several critical optimization steps. For protein extraction from yeast cells, use a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 10% glycerol, supplemented with protease inhibitors, and perform mechanical disruption using glass beads . Quantify total protein using Bradford or BCA assay and load 20-50μg per lane on SDS-PAGE gels (10-12% depending on the molecular weight of YNL011C). Include a molecular weight marker and positive control (recombinant YNL011C protein) in each run. Transfer proteins to PVDF membrane at 100V for 1 hour in transfer buffer containing 20% methanol. Post-transfer, confirm successful protein transfer using Ponceau S staining before proceeding with immunodetection. Block membranes with 5% non-fat dry milk in TBST for 1 hour at room temperature. Incubate with primary YNL011C antibody at 1:500-1:2000 dilution in blocking buffer overnight at 4°C . After washing three times with TBST (5 minutes each), apply HRP-conjugated anti-rabbit secondary antibody at 1:5000 dilution for 1 hour at room temperature. Wash again three times and develop using enhanced chemiluminescence (ECL) substrate. For troubleshooting weak signals, consider extended primary antibody incubation, increased antibody concentration, or signal amplification systems. For high background issues, increase washing stringency or dilute primary antibody further. Validate specificity by comparing signals from wild-type yeast versus YNL011C knockout strains. For quantitative analysis, use digital imaging systems with appropriate software for densitometric evaluation, normalizing to loading controls such as actin or GAPDH.

What controls should be implemented when using YNL011C antibody in experiments?

Implementing a comprehensive set of controls is essential for ensuring experimental validity when working with YNL011C antibody. For positive controls, include purified recombinant YNL011C protein at known concentrations to verify antibody functionality and establish detection limits . For negative controls, utilize samples from YNL011C knockout yeast strains to confirm signal specificity - any signal detected in these samples indicates potential cross-reactivity with other proteins. Include isotype controls (non-specific rabbit IgG at the same concentration as the primary antibody) to distinguish between specific binding and Fc receptor-mediated or other non-specific interactions. When performing immunohistochemistry or immunofluorescence, include secondary-antibody-only controls to assess background from the detection system. For quantitative experiments, prepare standard curves using purified recombinant YNL011C protein subjected to the same experimental conditions as test samples. Consider implementing peptide competition controls by pre-incubating the antibody with excess immunizing peptide before application to samples - this should eliminate specific signals if the antibody is functioning correctly. For experiments examining protein-protein interactions, include controls for non-specific binding to the matrix (beads or support) without antibody present. When testing specificity across species or related proteins, include samples containing homologous proteins from other organisms when available. Maintain detailed records of antibody lot numbers, as performance can vary between production batches, and consistently use the same positive and negative controls across experiments for reliable comparison.

How can YNL011C antibody performance be compared across different experimental platforms?

Systematic comparison of YNL011C antibody performance across multiple platforms requires standardized assessment criteria and consistent sample preparation. Begin by establishing a "gold standard" detection method, typically Western blotting with recombinant YNL011C protein at known concentrations, to serve as a reference point . For cross-platform comparison, prepare identical sample sets including positive controls (recombinant protein and wild-type yeast extracts) and negative controls (YNL011C knockout extracts) that will be analyzed in parallel across all platforms. When comparing ELISA and Western blot performance, evaluate detection limits, dynamic range, and signal-to-noise ratios using serial dilutions of the same samples. For immunoprecipitation efficiency assessment, quantify the percentage of target protein depleted from input samples and recovered in eluates across different buffer conditions and antibody concentrations. When evaluating immunofluorescence applications, systematically compare signal intensity, background levels, and localization patterns using fixed protocols for image acquisition and analysis. For advanced applications like ChIP or RIP, establish recovery efficiency using spike-in controls and PCR amplification of known target sequences. Develop a quantitative scoring system based on multiple parameters including specificity (signal in positive vs. negative controls), sensitivity (minimum detectable amount), reproducibility (coefficient of variation across replicates), and robustness (performance across different buffer conditions and sample types). When performing these comparisons, control for variables such as antibody concentration, incubation time, temperature, and detection methods. Document all findings in a standardized format to facilitate objective comparison and guide optimization efforts for specific research applications .

How can cross-reactivity issues with YNL011C antibody be identified and addressed?

Cross-reactivity represents a significant challenge when working with polyclonal antibodies like the YNL011C antibody . To systematically identify and address potential cross-reactivity, implement a multi-step approach. First, perform Western blot analysis using extracts from YNL011C knockout yeast strains - any bands detected represent cross-reactive proteins. Second, conduct epitope mapping to determine which regions of the YNL011C protein the antibody recognizes, then use sequence alignment tools to identify yeast proteins sharing similar epitopes. Third, perform immunoprecipitation followed by mass spectrometry to identify all proteins captured by the antibody under your experimental conditions . For confirmed cross-reactivity, several mitigation strategies can be employed: (1) implement more stringent washing conditions in immunoassays, gradually increasing salt concentration or detergent percentage until cross-reactive signals are minimized while maintaining specific signal; (2) pre-absorb the antibody with purified cross-reactive proteins or extracts from YNL011C knockout yeast; (3) employ competition assays with synthetic peptides representing the epitope to confirm binding specificity; (4) consider immunodepletion approaches to selectively remove cross-reactive antibodies from the polyclonal mixture; (5) for critical experiments where absolute specificity is required, consider developing monoclonal antibodies against unique epitopes of YNL011C. Document all cross-reactivity observations meticulously, as this information may provide valuable insights about structural similarities between YNL011C and other yeast proteins that could inform functional studies about protein families and evolutionary relationships .

What strategies can address weak or inconsistent signals when using YNL011C antibody?

Addressing weak or inconsistent signals with YNL011C antibody requires systematic troubleshooting of multiple experimental parameters. First, verify antibody functionality using recombinant YNL011C protein as a positive control under denaturing and non-denaturing conditions to determine if epitope recognition is conformation-dependent . For protein extraction from yeast, optimize lysis conditions by testing different buffer compositions (varying detergents, salt concentrations, and pH) and mechanical disruption methods to maximize protein recovery while preserving epitope integrity. Consider protein abundance - YNL011C may be expressed at low levels under standard conditions, requiring sample enrichment through immunoprecipitation prior to detection or growth under conditions that upregulate expression. For Western blotting, implement signal enhancement strategies including extended substrate incubation times, more sensitive detection reagents (e.g., femto-level ECL substrates), or signal amplification systems (tyramide signal amplification). For immunofluorescence applications, consider antigen retrieval techniques and signal amplification through biotin-streptavidin systems. Optimize primary antibody concentration through systematic titration, typically testing concentrations ranging from 0.1-10μg/ml. Extend incubation times (overnight at 4°C rather than 1-2 hours at room temperature) to allow more complete epitope binding. If signals remain weak after thorough optimization, consider protein modification status - post-translational modifications might affect epitope recognition, warranting investigation of different sample preparation methods that preserve or remove specific modifications. For batch-to-batch variability issues, implement internal standardization using consistent positive controls across experiments, and consider ordering larger antibody quantities from a single lot for long-term studies .

How can YNL011C antibody be used to investigate protein-protein interactions in yeast?

Investigating protein-protein interactions using YNL011C antibody requires optimization of co-immunoprecipitation (co-IP) protocols specifically tailored to yeast systems. Begin by selecting appropriate lysis conditions that preserve protein complexes - typically buffers containing 0.1-0.5% non-ionic detergents (NP-40, Triton X-100), 100-150mM salt, and 5-10% glycerol supplemented with protease and phosphatase inhibitors . Critical parameters include mechanical disruption method (glass bead beating at 4°C is often optimal for yeast cells), antibody coupling strategy (direct coupling to activated beads versus indirect capture using Protein A/G), and washing stringency (which modulates between complex preservation and background reduction). For detecting transient or weak interactions, consider implementing in vivo crosslinking with formaldehyde (0.1-1%) or membrane-permeable crosslinkers like DSP prior to lysis. After immunoprecipitation with YNL011C antibody, analyze captured complexes through methods including Western blotting against suspected interaction partners, mass spectrometry for unbiased identification, or functional assays to assess biological activity of the complex. For validation, perform reciprocal co-IPs using antibodies against identified partners, and compare interaction profiles between wild-type and mutant YNL011C variants . To distinguish between direct and indirect interactions, complement co-IP data with techniques such as proximity ligation assay in fixed yeast cells or recombinant protein binding assays. For capturing dynamic interaction networks under different physiological conditions, perform parallel co-IPs from yeast grown under various stress conditions or developmental stages. Integration with genetic interaction data can provide additional context for interpreting physical interaction results, potentially revealing functional consequences of the identified interactions .

What experimental approaches can identify post-translational modifications of YNL011C using the antibody?

Identifying post-translational modifications (PTMs) of YNL011C requires specialized approaches utilizing the antibody in combination with additional techniques. First, determine whether the YNL011C antibody's epitope recognition is affected by modification states by comparing immunoreactivity across samples treated with various phosphatases, deglycosylation enzymes, or deubiquitinases . For phosphorylation analysis, immunoprecipitate YNL011C using the antibody, then probe Western blots with phospho-specific antibodies (anti-phosphoserine, anti-phosphothreonine, anti-phosphotyrosine) or perform mass spectrometry analysis of the immunoprecipitated protein. Two-dimensional gel electrophoresis followed by Western blotting can reveal charge variants of YNL011C indicative of phosphorylation or other charged modifications. For glycosylation assessment, compare the molecular weight of immunoprecipitated YNL011C before and after treatment with endoglycosidases (PNGase F for N-linked glycans, O-glycosidase for O-linked glycans). For ubiquitination and SUMOylation analysis, perform immunoprecipitation under denaturing conditions to disrupt non-covalent interactions, then probe with anti-ubiquitin or anti-SUMO antibodies. Alternatively, co-express epitope-tagged ubiquitin or SUMO constructs in yeast and perform tandem purification combining YNL011C immunoprecipitation with affinity purification of the tagged modifier. For site-specific modification mapping, combine immunoprecipitation with mass spectrometry techniques such as multiple reaction monitoring (MRM) or parallel reaction monitoring (PRM) targeting predicted modification sites based on consensus sequences or evolutionary conservation . For functional relevance assessment, compare modification profiles across different growth conditions, stress responses, or cell cycle stages, correlating changes with alterations in YNL011C activity, localization, or interaction partners.

How can YNL011C antibody be used in genetic and evolutionary studies of yeast?

The YNL011C antibody serves as a valuable tool for exploring genetic and evolutionary aspects of Saccharomyces cerevisiae biology through several strategic approaches. For comparative studies across yeast species, test cross-reactivity of the antibody with homologous proteins in related yeasts such as S. paradoxus, S. bayanus, or more distant species like Candida albicans, establishing evolutionary conservation of epitope regions . In studies of genetic variants, use the antibody to compare protein expression levels and molecular weights between laboratory strains (like S288c) and wild isolates, potentially revealing functional adaptations in YNL011C. For mutational studies, create a panel of yeast strains expressing targeted mutations in YNL011C, then use the antibody to assess effects on protein stability, expression level, localization, and interaction partners, providing insights into structure-function relationships. In evolutionary rescue experiments similar to those performed with SEC53, investigate how YNL011C expression changes during adaptive evolution under selective pressure, using the antibody to track protein abundance changes over generations . For gene duplication studies, determine whether the antibody recognizes paralogous proteins in yeast, providing insights into functional divergence following duplication events. In synthetic genetic array (SGA) or synthetic dosage lethality (SDL) screens, use the antibody to verify expression levels in strains showing genetic interactions with YNL011C, establishing whether interactions occur at the genetic or protein level. For regulatory network mapping, employ the antibody in ChIP experiments (if YNL011C has DNA-binding capabilities) or monitor protein expression changes in response to deletion of various transcription factors. Finally, in comparative functional genomics, use the antibody to assess conservation of protein-protein interactions across species, providing insights into the evolution of molecular pathways involving YNL011C .

YNL011C Antibody Technical Specifications

Recommended Antibody Dilutions for Different Applications